Lagardere SA
LSE:0HB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lagardere SA
LSE:0HB2
|
FR |
|
S
|
Seelos Therapeutics Inc
F:NXEN
|
US |
|
D
|
Dai-ichi Life Holdings Inc
F:QHH
|
JP |
Wall St Price Targets
0HB2 Price Targets Summary
Lagardere SA
According to Wall Street analysts, the average 1-year price target for 0HB2 is 29.78 EUR with a low forecast of 23.9 EUR and a high forecast of 36.47 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0HB2's stock price target?
Price Target
29.78
EUR
According to Wall Street analysts, the average 1-year price target for 0HB2 is 29.78 EUR with a low forecast of 23.9 EUR and a high forecast of 36.47 EUR.
What is the Revenue forecast for Lagardere SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 4%.
What is the Operating Income forecast for Lagardere SA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Lagardere SA?
Projected CAGR
20%
The compound annual growth rate for Net Income over the next 3 years is 20%.
